Skin care
Medicated Skin Care in Canada
| Publication Date | April 2009 |
| Publisher | Euromonitor International |
| Product Type | Report |
| Pages | 35 |
| ISBN Number | not applicable |
| Product Code | EUR00217 |
Summary
Euromonitor International's Medicated Skin Care in Canada report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2013 illustrate how the market is set to change.
Product coverage: acne treatments, antipruritics, topical germicidals/antiseptics, topical allergy remedies/antihistamines, topical antifungals, vaginal antifungals, antiparasitics/lice (head and body) treatments, medicated shampoos, hair loss treatments, lip care treatments, haemorrhoid treatments, child-specific medicated skin care, nappy (diaper) rash treatments
Data coverage: market sizes (historic and forecasts), company shares and brand shares
Why buy this report?
- Get a detailed picture of the medicated skin care industry
- Identify factors driving change
- Understand the competitive environment, the market's major players and leading brands
- Use five-year forecasts to assess how the market is predicted to develop
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning
Contents
- Medicated Skin Care in Canada
- Euromonitor International
- April 2009
- Executive Summary
- Quiet Year and Slow Growth of Mature Market
- Ageing Population Remains the Principal Driver of Sales
- Private Label Gained Ground
- Chained Parapharmacies/drugstores Lead OTC Distribution
- Slow Growth Is Expected in the Coming Years
- Key Trends and Developments
- Ageing Population and Tendency To Self-medicate Remain Primary Growth Drivers
- Private Label Is Gaining Ground As Economy Weakens
- Most Natural Remedies Are Struggling
- Foreign-based Manufacturers Lead Sales
- Large Drugstore Chains Still Prevail in Distribution of OTC Healthcare
- Market Indicators
- Market Data
- $1OTC Registration and Classification
- Self-medication and Preventive Medicine
- Generics
- Switches
- Definitions
- Apotex Inc
- Strategic Direction
- Key Facts
- Company Background
- Competitive Positioning
- Ce Jamieson & Co Ltd
- Strategic Direction
- Key Facts
- Company Background
- Competitive Positioning
- Cv Technologies Inc
- Strategic Direction
- Key Facts
- Company Background
- Competitive Positioning
- Pharmascience Inc
- Strategic Direction
- Key Facts
- Company Background
- Competitive Positioning
- Swiss Herbal Remedies Ltd
- Strategic Direction
- Key Facts
- Company Background
- Competitive Positioning
- Headlines
- Trends
- Switches
- Competitive Landscape
- Prospects
- Sector Data
- List of Summaries
- Summary 1 OTC Healthcare Switches 2005-2008
- Summary 2 Research Sources
- Summary 3 Apotex Inc: Key Facts
- Summary 4 CE Jamieson & Co Ltd: Key Facts
- Summary 5 CE Jamieson & Co Ltd: Competitive Position 2008
- Summary 6 CV Technologies Inc: Key Facts
- Summary 7 CV Technologies Inc: Operational Indicators
- Summary 8 CV Technologies Inc: Competitive Position 2008
- Summary 9 Pharmascience Inc: Key Facts
- Summary 10 Pharmascience Inc: Competitive Position 2008
- Summary 11 Swiss Herbal Remedies Ltd: Key Facts
- Summary 12 Swiss Herbal Remedies Ltd: Competitive Position 2008
- List of Tables
- Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
- Table 2 Life Expectancy at Birth 2003-2008
- Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
- Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
- Table 5 OTC Healthcare Company Shares by Value 2004-2008
- Table 6 OTC Healthcare Brand Shares by Value 2005-2008
- Table 7 Penetration of Private Label by Sector 2003-2008
- Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
- Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
- Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
- Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
- Table 12 Sales of Medicated Skin Care by Subsector: Value 2003-2008
- Table 13 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
- Table 14 Acne Treatments by Format: % Value Breakdown 2004-2008
- Table 15 Medicated Skin Care Company Shares by Value 2004-2008
- Table 16 Medicated Skin Care Brand Shares by Value 2005-2008
- Table 17 Acne Treatments Brand Shares by Value 2005-2008
- Table 18 Hair Loss Treatments Brand Shares by Value 2005-2008
- Table 19 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
- Table 20 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013







